Korean J Gastroenterol.  2016 Nov;68(5):234-236. 10.4166/kjg.2016.68.5.234.

Efficacy of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer

• Jung JT

• KMID: 2383499
• DOI: http://doi.org/10.4166/kjg.2016.68.5.234

Abstract

No abstract available.

MeSH Terms

Drug Therapy*
Stomach Neoplasms*

Reference

References

1. Cancer inspected through statistics. [Internet]. Goyang: National Cancer Information Center;2013. [cited 2016 Nov 9]. Available from:. http://www.cancer.go.kr/mbs/cancer/sub-view.jsp?id=cancer_040101000000.

2. Hartgrink HH, van de Velde CJ, Putter H, et al. Neoadjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial. Eur J Surg Oncol. 2004; 30:643–649.

3. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006; 355:11–20.

4. Schuhmacher C, Gretschel S, Lordick F, et al. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. J Clin Oncol. 2010; 28:5210–5218.

5. Ychou M, Boige V, Pignon JP, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011; 29:1715–1721.

6. Sym SJ, Chang HM, Ryu MH, et al. Neoadjuvant docetaxel, capecitabine and cisplatin (DXP) in patients with unresectable locally advanced or metastatic gastric cancer. Ann Surg Oncol. 2010; 17:1024–1032.

7. Park I, Ryu MH, Choi YH, et al. A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma. Cancer Chemother Pharmacol. 2013; 72:815–823.

8. Jiang L, Yang KH, Guan QL, Chen Y, Zhao P, Tian JH. Survival benefit of neoadjuvant chemotherapy for resectable cancer of the gastric and gastroesophageal junction: a metaanalysis. J Clin Gastroenterol. 2015; 49:387–394.

9. Kim JS, Kang SH, Moon HS, Sung JK, Jeong HY, Sul JY. Clinical outcome of doublet and triplet neoadjuvant chemotherapy for locally advanced gastric cancer. Korean J Gastroenterol. 2016; 68:245–252.